Amneal Pharmaceuticals Inc banner
A

Amneal Pharmaceuticals Inc
F:2DT

Watchlist Manager
Amneal Pharmaceuticals Inc
F:2DT
Watchlist
Price: 10.5 EUR 2.94% Market Closed
Market Cap: €3.2B

Balance Sheet

Balance Sheet Decomposition
Amneal Pharmaceuticals Inc

Balance Sheet
Amneal Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2001 Dec-2002 Dec-2003 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
15
10
16
56
6
38
69
32
92
104
142
185
215
340
180
182
213
151
341
248
26
92
111
282
Cash Equivalents
15
10
16
56
6
38
69
32
92
104
142
185
215
340
180
182
213
151
341
248
26
92
111
282
Short-Term Investments
20
0
0
0
23
106
51
59
257
242
157
229
200
0
0
0
0
0
0
0
0
0
0
0
Total Receivables
4
7
10
31
62
52
43
186
82
154
92
113
147
325
257
302
529
636
674
728
797
646
809
940
Accounts Receivables
4
7
10
31
62
52
43
186
82
154
92
113
147
325
257
241
482
604
639
663
742
614
776
895
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61
47
32
35
65
55
32
33
45
Inventory
4
11
29
33
34
28
32
49
45
54
90
70
81
126
175
159
457
381
491
489
531
581
612
606
Other Current Assets
2
1
1
9
55
48
41
49
46
46
65
64
34
32
18
53
87
42
45
55
58
59
56
83
Total Current Assets
44
28
55
129
181
271
236
374
521
600
546
660
676
822
631
696
1 287
1 210
1 552
1 520
1 412
1 378
1 588
1 911
PP&E Net
24
37
38
55
69
81
96
102
106
118
181
188
188
214
233
125
544
620
605
639
589
550
524
550
PP&E Gross
24
37
38
55
69
81
96
102
106
118
181
188
188
214
233
125
544
620
605
639
589
550
524
550
Accumulated Depreciation
4
6
9
18
25
32
40
50
63
75
87
100
116
133
156
116
209
276
332
395
446
508
564
606
Intangible Assets
6
1
0
0
0
0
0
0
0
2
48
30
27
602
621
263
1 655
1 383
1 305
1 167
1 096
890
732
563
Goodwill
35
28
28
28
28
28
28
28
28
28
28
28
28
210
207
207
426
420
523
593
599
599
597
595
Other Long-Term Assets
1
11
11
49
66
137
155
158
39
46
62
92
161
74
131
61
441
33
22
21
103
56
60
58
Other Assets
35
28
28
28
28
28
28
28
28
28
28
28
28
210
207
207
426
420
523
593
599
599
597
595
Total Assets
98
N/A
104
+7%
133
+27%
260
+96%
344
+32%
517
+50%
514
0%
661
+28%
693
+5%
794
+15%
864
+9%
997
+15%
1 079
+8%
1 923
+78%
1 823
-5%
1 351
-26%
4 353
+222%
3 666
-16%
4 006
+9%
3 940
-2%
3 799
-4%
3 473
-9%
3 501
+1%
3 678
+5%
Liabilities
Accounts Payable
4
8
23
13
15
17
13
23
19
23
41
27
32
56
59
81
115
102
151
189
166
144
259
255
Accrued Liabilities
4
11
11
48
30
36
41
116
87
110
96
102
126
270
245
248
400
410
464
404
383
403
490
518
Short-Term Debt
0
4
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60
179
100
0
Current Portion of Long-Term Debt
0
1
1
0
2
69
14
0
0
0
0
0
0
0
18
18
22
24
48
34
33
37
227
10
Other Current Liabilities
0
0
0
12
52
38
41
65
21
24
8
25
1
1
0
7
18
15
13
50
110
84
54
99
Total Current Liabilities
8
23
42
73
99
160
110
204
126
157
145
154
159
327
321
354
554
550
677
677
753
847
1 130
882
Long-Term Debt
7
9
9
80
90
21
6
0
0
0
0
0
0
425
814
770
2 670
2 675
2 834
2 778
2 692
2 486
2 219
2 620
Deferred Income Tax
0
0
0
1
0
0
0
0
0
0
0
0
0
73
0
3
1
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
392
115
54
24
89
42
65
77
Other Liabilities
23
24
8
98
160
201
239
235
59
34
28
33
33
36
64
37
232
94
138
100
145
79
198
171
Total Liabilities
38
N/A
56
+48%
59
+6%
251
+325%
348
+38%
382
+10%
355
-7%
439
+24%
185
-58%
191
+3%
173
-9%
187
+8%
191
+2%
860
+350%
1 199
+39%
1 164
-3%
3 848
+231%
3 434
-11%
3 703
+8%
3 579
-3%
3 501
-2%
3 453
-1%
3 611
+5%
3 749
+4%
Equity
Common Stock
8
8
8
1
1
1
1
1
1
1
1
1
1
1
1
1
3
3
3
3
3
3
3
3
Retained Earnings
70
90
105
174
186
60
49
1
251
317
373
474
531
570
98
372
21
378
287
276
406
490
607
535
Additional Paid In Capital
123
131
170
183
184
196
211
223
255
286
315
337
364
504
535
560
530
607
628
658
692
539
560
572
Treasury Stock
0
0
0
0
2
2
2
2
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
Other Equity
1
0
0
0
0
0
1
1
3
2
5
1
6
11
8
1
8
0
41
25
10
32
66
111
Total Equity
60
N/A
49
-19%
74
+51%
9
-88%
4
N/A
134
N/A
159
+19%
222
+39%
508
+129%
603
+19%
691
+15%
810
+17%
888
+10%
1 062
+20%
624
-41%
187
-70%
505
+170%
232
-54%
303
+31%
360
+19%
298
-17%
20
-93%
109
N/A
71
+35%
Total Liabilities & Equity
98
N/A
104
+7%
133
+27%
260
+96%
344
+32%
517
+50%
514
0%
661
+28%
693
+5%
794
+15%
864
+9%
997
+15%
1 079
+8%
1 923
+78%
1 823
-5%
1 351
-26%
4 353
+222%
3 666
-16%
4 006
+9%
3 940
-2%
3 799
-4%
3 473
-9%
3 501
+1%
3 678
+5%
Shares Outstanding
Common Shares Outstanding
47
48
55
59
59
59
60
62
65
67
68
70
71
73
74
74
299
299
300
302
304
459
310
315
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett